Toggle light / dark theme

FTC gives Musk the OK to acquire SpaceX alumni startup Mesh

Mesh Optical came out of stealth in February when it announced that it raised a $50 million Series A led by Thrive Capital.

Before founding Mesh Optical, the startup’s co-founders, Travis Brashears, Cameron Ramos, and Serena Grown-Haeberli, developed the optical communication links that keep thousands of SpaceX’s Starlink satellites interconnected.

The Mesh co-founders saw an opportunity to develop optical transceivers for terrestrial data centers, as light-based hardware is faster and more energy-efficient than traditional electrical-based systems.

Artificial ‘leaf’ powers wireless biomedical device

Plants convert light into energy efficiently through photosynthesis—an ability that scientists and engineers still struggle to match with electronic devices. Recently, researchers have looked beyond traditional semiconductor materials to create devices using a promising class of materials called nanoplasmonics. These tiny metal structures can absorb and concentrate optical energy and generate energetic charge carriers.

In a new study, researchers from the University of Chicago Pritzker School of Molecular Engineering (UChicago PME) and Department of Chemistry developed a nanoplasmonic “leaf,” a wireless bioelectronic device they used to stimulate nerves and pace heartbeats in an animal model.

The team also showed that their material could be used as a computer-like sensing platform, where users can interact with the screen using invisible light—a potentially secure way to transmit information.

Dog-bone design helps 2D nanoribbon transistors stay fast and efficient as widths shrink

Transistors, small semiconductor-based switches that control the flow of electricity, are central components of all electronic devices, from computers to smartphones, wearables, sensors and smart appliances. Over the past decades, electronics engineers have been continuously working to boost the speed and performance of transistors while also reducing their size.

A promising approach for miniaturizing transistors entails the use of two-dimensional (2D) semiconductors, materials that are only one or a few atoms thick. Despite their potential, most high-performing 2D transistors have so far been demonstrated using relatively wide channels, and it has remained unclear whether their performance can be preserved when the channels are made much narrower.

Researchers at Stanford University recently developed new compact transistors based on narrow strips of monolayer 2D semiconducting materials known as nanoribbons. These transistors, introduced in a paper published in Nature Nanotechnology, were found to perform remarkably well despite their small size, outperforming previously developed nanoribbon transistors based on the same 2D materials.

The Role of [18F]FDG PET/CT in Predicting Toxicity in Patients with NHL Treated with CAR-T: A Systematic Review

CAR-T-cell therapy, also referred to as chimeric antigen receptor T-cell therapy, is a novel method in the field of immunotherapy for the treatment of non-Hodgkin’s lymphoma (NHL). In patients receiving CAR-T-cell therapy, fluorodeoxyglucose Positron Emission Tomography/Computer Tomography ([18F]FDG PET/CT) plays a critical role in tracking treatment response and evaluating the immunotherapy’s overall efficacy. The aim of this study is to provide a systematic review of the literature on the studies aiming to assess and predict toxicity by means of [18F]FDG PET/CT in patients with NHL receiving CAR-T-cell therapy. PubMed/MEDLINE and Cochrane Central Register of Controlled Trials (CENTRAL) databases were interrogated by two investigators to seek studies involving the use of [18F]FDG PET/CT in patients with lymphoma undergoing CAR-T-cell therapy.

Invasive neurophysiology and whole brain connectomics for neural decoding in patients with brain implants

A modularized open-source pipeline for invasive brain signal decoding bridges the gap between closed-loop neuromodulation and clinical brain–computer interface approaches in a large patient cohort.

/* */